STAT September 28, 2023
Damian Garde and Allison DeAngelis

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, FDA, Govt Agencies, Pharma / Biotech, Trends
GPUs go biological: BBB unveils Bionode, lab-grown, living neuron compute for AI applications
The Download: speaking to robots, and growing pharmaceutical mushrooms
Sofinnova closes new fund and backs a trio of new biotechs
AstraZeneca's $1 Billion Deal Highlights Growing Interest in In Vivo Cell Therapies
Pharmacists Play Key Role in Supporting Patients Using GLP-1s

Share This Article